A change of strategy in the war on cancer

被引：276

作者：

Gatenby, Robert A. ^{[1
,2
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA

来源：

NATURE | 2009年 / 459卷 / 7246期

关键词：

RIBONUCLEOTIDE REDUCTASE; CELL-LINES; RESISTANCE;

D O I：

10.1038/459508a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Patients and politicians anxiously await and increasingly demand a 'cure' for cancer. But trying to control the disease may prove a better plan than striving to cure it, says Robert A. Gatenby.

引用

页码：508 / 509

页数：2

共 5 条

[1] An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines [J].

Davidson, JD ;

Ma, LD ;

Flagella, M ;

Geeganage, S ;

Gelbert, LM ;

Slapak, CA .

CANCER RESEARCH, 2004, 64 (11) :3761-3766

[2]

GATENBY RA, CANC RES IN PRESS

[3] Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase [J].

Gautam, Ashish ;

Bepler, Gerold .

CANCER RESEARCH, 2006, 66 (13) :6497-6502

[4] Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma [J].

Izzo, Julie G. ;

Correa, Arlene M. ;

Wu, Tsung-Teh ;

Malhotra, Usha ;

Chao, Clifford K. S. ;

Luthra, Rajyalakshmi ;

Ensor, Joe ;

Dekovich, Alexander ;

Liao, Zhongxing ;

Hittelman, Walter N. ;

Aggarwal, Bharat B. ;

Ajani, Jaffer A. .

MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) :2844-2850

[5] Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein [J].

Scappini, B ;

Gatto, S ;

Onida, F ;

Ricci, C ;

Divoky, V ;

Wierda, WG ;

Andreeff, M ;

Dong, L ;

Hayes, K ;

Verstovsek, S ;

Kantarjian, HM ;

Beran, M .

CANCER, 2004, 100 (07) :1459-1471

← 1 →